Democrats are looking to cap out-of-pocket Medicare drug costs at $2,000 and reduce the price of insulin, as part of President Biden’s $1.75 trillion domestic policy proposal.
prescription drugs
Posted inOp-Eds, Opinion
Commentary: Medicare must study unproven, expensive Alzheimer’s drug
Taxpayers and patients cannot afford to pay a high price for a treatment not known to be effective.
advertisement
Posted inOp-Eds, Opinion
Commentary: Generic prescriptions deliver savings for Maine patients
An op-ed and an editorial praising proposed state regulations overlook the fact that brand-name drugs are consistently more costly to Maine.
Posted inMaine Voices, Op-Eds, Opinion
Maine Voices: Legislators must take action to keep prescription drug prices in line
Lawmakers should not yield to intimidation from those who profit by jacking up prices on medicines Mainers need.
Posted inOp-Eds, Opinion
Commentary: Congress should stop rewarding Big Pharma with tax breaks for gouging patients
Maine’s congressional delegation should push to eliminate loopholes that allow this industry to dodge paying its fair share.
Posted inBusiness, Health, Local & State, News, Politics
Legislative panel votes down bill to penalize drug companies for price gouging
The pharmaceutical industry has made it clear that it will sue Maine if the state approves the ‘excessive pricing’ bill, which now goes to the full Legislature.
Posted inOp-Eds, Opinion
Commentary: Don’t put Maine’s health care decisions in the hands of a third party
L.D. 675 could cost thousands of Maine patients and their families access to the medications that allow them to live fulfilling lives, says the mother of a chronically ill teen.
Posted inBusiness, Health, Local & State, News, Politics
Maine Democrats’ bills aim to hold down prescription drug prices, health care costs
Their 5 bills include proposals to reduce price gouging by pharmaceutical companies and help consumers who have trouble paying for insulin.
Posted inOp-Eds, Opinion
Sen. Libby: Maine stands up to drug companies looking to profit off a crisis
Legislators have passed bills aimed at medication cost control and billing transparency – now we must focus on reining in the price of treating COVID.
Posted inEditorials, Opinion
Our View: Don’t let companies off the hook for their role in opioid epidemic
An investigation by ProPublica found evidence that Walmart sent millions of doses of opioid painkillers to criminal doctors.